case_images: PMC9926943_01
case_images: Pre-operative axial CT section at upper abdomen showing an enhancing mass in the tail of the pancreas
case_images: cureus-0015-00000033788-i01.jpg
case_images: PMC9926943_01_cureus-0015-00000033788-i01.jpg
case_images: FIG1
case_images: His further workup included a computed tomography scan of the abdomen (Figure 1) followed by endoscopic ultrasound-guided FNAB (fine needle aspiration biopsy) of pancreatic masses, which led to a clinical diagnosis of neuroendocrine tumor.
case_images: Ga-68 DOTA PET/CT pre-operative image showing pancreatic mass with increased uptake. DOTA - dodecane tetraacetic acid, PET - positron emission tomography
case_images: cureus-0015-00000033788-i02.jpg
case_images: PMC9926943_01_cureus-0015-00000033788-i02.jpg
case_images: FIG2
case_images: Given the aforementioned biochemical investigations and imaging, Ga-68 dodecane tetraacetic acid (DOTA) positron emission tomography (PET)/CT was performed to rule out any other foci (Figure 2), which was diagnostic of a neuroendocrine tumor.
case_images: Axial CT showing post-operative changes with visible surgical staples
case_images: cureus-0015-00000033788-i03.jpg
case_images: PMC9926943_01_cureus-0015-00000033788-i03.jpg
case_images: FIG3
case_images: The patient was followed up in the clinic after three months with both biochemical investigations and imaging (Figures 3, 4), neither of which showed any evidence of recurrence.
case_images: CT chest/abdomen coronal image showing post-operative changes with no evidence of recurrence
case_images: cureus-0015-00000033788-i04.jpg
case_images: PMC9926943_01_cureus-0015-00000033788-i04.jpg
case_images: FIG4
case_images: The patient was followed up in the clinic after three months with both biochemical investigations and imaging (Figures 3, 4), neither of which showed any evidence of recurrence.